Why We Invested: TruLite Health
Osage Venture Partners is excited to announce that we recently led the $7M Series A round for TruLite Health (“TruLite”), the industry’s first comprehensive health equity platform that detects and addresses clinical bias at the point of care. TruLite was founded in 2021 by accomplished healthcare leaders who are committed to breaking the chain of […]
Full ArticleWhy We Invested: Curavit
Osage Venture Partners is excited to announce that we recently led the $5M Series A round for Curavit, a full-service virtual contract research organization (VCRO) focused on designing and executing digital-first decentralized clinical trials (DCTs). Founded in 2020 by experts with decades of experience in technology and clinical research, Curavit leverages emerging technologies in digital […]
Full ArticleWhy We Invested: TeachFX
Osage Venture Partners is excited to announce that we recently participated in the $10M Series A round for TeachFX, a company changing the future of education by empowering educators to drive greater student outcomes through technology that provides frequent and meaningful feedback on their practice. Despite knowing that teacher quality is the most significant in-classroom […]
Full Article